A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer
מצבים רפואיים
Carcinoma, Non-Small-Cell Lung
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
Birmingham, Alabama, United States
Tucson, Arizona, United States
Loma Linda, California, United States
Sacramento, California, United States
San Francisco, California, United States
Aurora, Colorado, United States
Tampa, Florida, United States
Atlanta, Georgia, United States
Lafayette, Indiana, United States
Boston, Massachusetts, United States
St Louis, Missouri, United States
Buffalo, New York, United States
New York, New York, United States
Cincinnati, Ohio, United States
Portland, Oregon, United States
Pittsburgh, Pennsylvania, United States
Charleston, South Carolina, United States
Nashville, Tennessee, United States
Dallas, Texas, United States
Edmonton, Alberta, Canada
Toronto, Ontario, Canada
Montreal, Quebec, Canada
Heidelberg, Mannheim, Germany
Bad Berka, Germany
Frankfurt, Germany
Heidelberg, Germany
Lungenklinik, Germany
Ulm, Germany
Seoul, Gangnam-gu, South Korea
Seoul, Seodaemun-gu, South Korea
Barcelona, Spain
Madrid, Spain
Málaga, Spain
Guishan, Taoyuan County, Taiwan
Taichung, Taiwan
Taichung, Taiwan
Tainan, Taiwan
Taipei, Taiwan
מובילי המחקר
Victor Moyo, MD
Study Director
Merrimack Pharmaceuticals